ProfileOfResearchers

TÃTULO: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study Full Text
AUTORES: Kuemmel, Sherko; Schmid, Peter; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Boileau, Jean Francois; Cortes, Javier; McArthur, Heather; Dent, Rebecca; O'Shaughnessy, Joyce; Pusztai, Lajos; Foukakis, Theodoros; Park, Yeon Hee; Hui, Rina; Cardoso, Fatima; Denkert, Carsten; Zhu, Yalin; Pan, Wilbur; Karantza, Vassiliki; Fasching, Peter A.;
PUBLICAÇÃO: 2023, FONTE: 24th Annual Meeting of The American Society of Breast Surgeons (ASBrS) in ANNALS OF SURGICAL ONCOLOGY, VOLUME: 30, NÚMERO: SUPPL 2

INDEXADO EM:

WOS

TÃTULO: Pembrolizumab for Early Triple-Negative Breast Cancer
AUTORES: Peter Schmid; Javier Cortes; Lajos Pusztai; Heather McArthur; Sherko Kuemmel; Jonas Bergh; Carsten Denkert; Yeon Hee Park; Rina Hui; Nadia Harbeck; Masato Takahashi; Theodoros Foukakis; Peter A Fasching; Fatima Cardoso; Michael Untch; Liyi Jia; Vassiliki Karantza; Jing Zhao; Gursel Aktan; Rebecca Dent; Joyce O'Shaughnessy; ...Mais
PUBLICAÇÃO: 2020, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 382, NÚMERO: 9

INDEXADO EM:

Scopus

WOS

TÃTULO: Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial
AUTORES: Suzette Delaloge; Martine Piccart; Emiel Rutgers; Saskia Litiere; Laura J van't Veer; Franchette van den Berkmortel; Etienne Brain; Aleksandra Dudek Peric; Miguel Gil Gil; Patricia Gomez; Florentine S Hilbers; Zaman Khalil; Susan Knox; Sherko Kuemmel; Georg Kunz; Anne Lesur; Jean Yves Pierga; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; Tineke J Smilde; Alastair M Thompson; Giuseppe Viale; Gabriele Zoppoli; Peter Vuylsteke; Konstantinos Tryfonidis; Coralie Poncet; Jan Bogaerts; Fatima Cardoso; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 11

INDEXADO EM:

Scopus

WOS

TÃTULO: MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
AUTORES: Fatima Cardoso; Laura van't Veer; Coralie Poncet; Josephine Lopes Cardozo; Suzette Delaloge; Jean Yves Pierga; Peter Vuylsteke; Etienne Brain; Giuseppe Viale; Sherko Kuemmel; Isabel T Rubio; Gabriele Zoppoli; Alastair Mark Thompson; Erika Matos; Khalil Zaman; Florentine Hilbers; Aleksandra Dudek Peric; Bart Meulemans; Martine J Piccart Gebhart; Emiel J Rutgers;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15

INDEXADO EM:

WOS

TÃTULO: Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer The MANTA Phase 2 Randomized Clinical Trial
AUTORES: Peter Schmid; Matthias Zaiss; Catherine Harper Wynne; Marta Ferreira; Sidharth Dubey; Stephen Chan; Andreas Makris; Gia Nemsadze; Adrian M Brunt; Sherko Kuemmel; Isabel Ruiz; Antonia Perello; Anne Kendall; Janet Brown; Hartmut Kristeleit; John Conibear; Cristina Saura; Julien Grenier; Karoly Mahr; Michael Schenker; Joohyuk Sohn; Keun Seok Lee; Christopher J Shepherd; Elisabeth Oelmann; Shah Jalal Sarker; Aaron Prendergast; Patricia Marosics; Atiyyah Moosa; Cheryl Lawrence; Carike Coetzee; Kelly Mousa; Javier Cortes; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA ONCOLOGY, VOLUME: 5, NÚMERO: 11

INDEXADO EM:

Scopus

WOS

Links Úteis